Neurological disorders are mostly chronic, long-term conditions. Those
affected may be at increased risk from Covid-19. However, as this strain of the
coronavirus is new, the knowledge on how this will affect people with
neurological disorders is still limited.
Based… Continue Reading
Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.
Latest Posts
-
-
New gene therapy to treat spinal muscular atrophy On March 27, European Medicines Agency (EMA) recommended granting a conditional marketing authorisation in the European Union for the gene therapy Zolgensma (onasemnogene abeparvovec) to treat babies and young children with spinal… Continue Reading -
The European Brain Research Area project – EBRA – was created as a catalyzing platform for brain research stakeholders (researchers, clinicians, patients, governments, funders and public institutions) to streamline and better coordinate brain research across Europe while fostering global initiatives.… Continue Reading
-
This document aims to update and clarify some emerging issues in the EAN guideline production, and introduces temporary solutions to unclear points in the guideline production process. State of the art and suggestions for the next two years I. State… Continue Reading
-
Discussions during last year’s Spring Meeting and General Assembly showed that BioMed Alliance Members are affected by Plan S. Due to COVID-19, adaptation to the open access initiative within the foreseen timeline has become even more challenging for medical societies.… Continue Reading -
EMA has published its Regulatory Science Strategy to 2025 today. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It comes in response to the dramatic acceleration of the… Continue Reading
-
Executive PageEAN NewsCOVID-19Top ArticlesFeatured SliderEXECUTIVE PAGE: EAN takes swift action against COVID-19 with dedicated initiative
Despite some positive slowing of new cases and deaths in some countries, the COVID-19 pandemic has infected until today over 3.5 million people, leading to more than 250,000 deaths across the globe. Without a doubt, the crisis sparked by this pandemic has also wreaked havoc on healthcare systems and economies while causing massive disruption to the everyday lives of people around the world. -
The BMA informs that the application form for the European Commission’s COVID-19 Clinical Management Support System is available here. The European Commission’s COVID-19Clinical Management Support System is based on experiences with the European Reference Networks. It aims to help create… Continue Reading
-
News from EAN member societiesCOVID-19
Alzheimer Europe rings the alarm about discriminatory practices in intensive care settings during the COVID-19 pandemic
At an online meeting organised by Alzheimer Europe, representatives from 22 national Alzheimer’s associations from 19 European countries adopted a call to governments and national health systems to urgently increase the infrastructure for intensive care needed for people affected by… Continue Reading -
Prof. B. Bodini interviews Mrs. Joke Jaarsma, President of EFNA – European Federation of Neurological Associations -
EAN News
Make sure to participate in the sessions dedicated to Clinical Neurophysiology on May 23, 2020, during the EAN Virtual Congress!
IFCN-EMEAC represents European, Middle Eastern and African specialists in Clinical Neurophysiology and organises a congress every 2 years in Europe, as well as advanced training courses. It also promotes and supports pre- and postgraduate education in Clinical Neurophysiology and encourages… Continue Reading -
EAN considers the production of neurological guidelines a major obligation, as this is a tool to improve clinical practice in neurology. Guideline production is in the hands of the Scientific Panels who decide to establish a specific task force (TF)… Continue Reading
-
News from EAN member societiesEAN NewsCOVID-19
Webinar on the Guidance on the management of clinical trials during the COVID-19 pandemic on 15 May 2020
The latest revision (v3) of the Guidance on how to manage clinical trials during the COVID-19 pandemic was published on 28 April. This version contains key changes based also on the feedback from different stakeholders’ groups (patients’ organisations, academia and… Continue Reading -
Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Dr. Bart van der Worp, President of the European Stroke Organisation. -
News from EAN member societiesOther NewsUncategorized
BioMed Alliance Task Force “Regulatory Affairs and Medical Devices”
Postponement of the application of the Medical Devices Regulation The European Commission adopted a proposal to postpone the application date of the Medical Devices regulation by one year, to 26 May 2021. The postponement is supposed to give authorities, manufacturers… Continue Reading